Jane Myles
Program Director
Decentralized Trials and Research Alliance
Jane has worked in clinical drug development for almost 30 years, starting her career at the bench at Eli Lilly. Over the course of her career, she led clinical trial teams, registrational filing teams, molecular asset decision teams and eventually led a global function focused on driving therapeutic area global patient recruitment and trial innovation. In her current role at DTRA, she has focused on chartering and delivering outputs across the Alliance's initiative teams. One of her key contributions has been the design and delivery of the DCT Tubestop, a digital playbook for DCT methods that's been positively received by FDA and other regulatory agencies, biopharmaceutical sponsors, and cross-industry consortia. Jane has been a core member of several initiative teams focused on supporting site adoption of DCT elements and other innovative trial solutions. Her roles in sponsor, CRO, and technology organizations offer her unique expertise in change management and innovation.